Ad
related to: Fda and Investors
Search results
CKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud Lawsuit
WTNH-TV New Haven· 18 hours agoLOS ANGELES, May 2, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that ...
Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 17 hours agoMartin Lange -- Executive Vice President, Head of Development Thank you, Doug. Please turn to the next slide. In March, we announced that the FDA has...
DEADLINE ALERT for PLUG, EVLV, BLUE, LUNA: Law Offices of Howard G. Smith Reminds Investors of Class...
Morningstar· 2 days agoLaw Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. ...
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 day agoWe have an increased demand for Xtandi, which continues to be a backbone therapy across the prostate cancer treatment continuum. And we have continued...
Abbott wins FDA approval for Esprit resorbable scaffold
MedTech Dive via Yahoo Finance· 3 days agoThe device is designed to keep vessels open to deliver the immunosuppressant everolimus before the...
Monogram Provides Regulatory Update Following Meeting with FDA
Digital Journal· 2 days agoFood and Drug Administration (the "FDA"). On April 19, 2024, Monogram received written feedback from the FDA regarding the Company's Q1 2023 pre-submission ...
Earnings call: NovoCure reports growth and clinical advances in Q1 2024 By Investing.com
Investing.com· 12 hours agoThe company reported a 13% year-over-year increase in net revenues to $139 million and an 11%...
Here's Why Eli Lilly Stock Remains a Screaming Buy
Motley Fool via Yahoo Finance· 1 day agoIt also resubmitted for FDA approval of the drug in treating atopic dermatitis following a complete response letter from the agency due to issues with a...
FDA approves Abbott's dissolving stent for leg artery disease By Investing.com
Investing.com· 4 days agoThe U.S. Food and Drug Administration has approved Abbott's Esprit BTK Everolimus Eluting Resorbable...
Altria CEO Urges FDA Crackdown On Illicit Vape Products: Report - Altria Group (NYSE:MO)
Benzinga· 7 days agoAltria CEO, Billy Gifford, urges FDA crackdown on illicit vape products, highlighting public health...